Saratov JOURNAL of Medical and Scientific Research

Rituximab treatment efficacy in a patient with systemic lupus erythematosus with severe thrombocytopenia

Year: 2018, volume 14 Issue: №3 Pages: 417-419
Heading: rheumatology Article type: Case report
Authors: Alexandrova O.L., Nikitina N.M., Magdeeva N.A., Shmelkova M.Yu., Grigoryeva S.N.
Organization: Saratov Regional Clinical Hospital, Saratov State Medical University

The article presents a clinical case of systemic lupus erythematosus with severe thrombocytopenia in a 55 year old patient. The standard therapy of usage of high doses of glucocorticoids, cyclophosphamide and intravenous im-munoglobulin was not effective. Application of Rituximab improved the course of disease, decreased the severity of thrombocytopenia, led to disappearance of leucopenia and anemia.

1. Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007; 56 (7): 2344-51
2. Doha A, laccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119 (8): 700-6
3. Nasonov EL, Aleksandrova EN, NovikovAA. Autoimmune Rheumatic Diseases — Problems of Immunopathology and Personalized Treatment. Annals of the Russian Academy of Medical Sciences 2015; 2: 169-82
4. Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program 2012: 191-7
5. Melikyan AL, Pustovaya El, Kalinina MV, et al. Diagnostic approach for thrombocytopenia. Hematology and Transfusiology 2016; 61 (1 Suppl 1): 23
6. Melikyan AL, Pustovaya El, Egorova EK, et al. Differential diagnosis of thrombocytopenies. Oncohematology 2017; 12 (1): 78-87
7. Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 11 (26): 6511-21
8. Soloviev SK, Aseeva EA, Torgashina AV. Intensive therapy of autoimmune rheumatic diseases. RMJ 2010; 11 (375); 18: 748-51
9. Chambers SA, Isenberg DA. Anti-B-cell therapy (Rituximab) in the treatment of autoimmune disease. Lupus 2005; 14(3): 210-4
10. Tsanyan ME, Soloviev SK, Torgashina AV, etal. Rituximab treatment efficacy in patient with systemic lupus erythematosus refractory to standart therapy in the long-term follow-up. Rheumatology Science and Practice 2014; 52 (2): 159-68
11. Jovancevic В, Lindholm С, Pullerits R. Anti-B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Lupus 2013; 22 (7): 664-74.

2018_3_417-419.pdf268.86 KB

No votes yet